These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 37902028)
1. Design, synthesis and biological evaluation of novel indanones derivatives as potent acetylcholinesterase/monoamine oxidase B inhibitors. Hu Z; Zhou S; Li J; Li X; Zhou Y; Zhu Z; Xu J; Liu J Future Med Chem; 2023 Oct; 15(20):1823-1841. PubMed ID: 37902028 [No Abstract] [Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease. Li X; Li T; Zhan F; Cheng F; Lu L; Zhang B; Li J; Hu Z; Zhou S; Jia Y; Allen S; White L; Phillips J; Zhu Z; Xu J; Yao H ACS Chem Neurosci; 2022 Dec; 13(23):3488-3501. PubMed ID: 36383455 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Tan Z Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875 [TBL] [Abstract][Full Text] [Related]
4. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties. Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057 [TBL] [Abstract][Full Text] [Related]
5. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease. Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051 [TBL] [Abstract][Full Text] [Related]
6. Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease. Campora M; Canale C; Gatta E; Tasso B; Laurini E; Relini A; Pricl S; Catto M; Tonelli M ACS Chem Neurosci; 2021 Feb; 12(3):447-461. PubMed ID: 33428389 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease. Huang ST; Luo JC; Zhong GH; Teng LP; Yang CY; Tang CL; Jing L; Zhou ZB; Liu J; Jiang N Drug Des Devel Ther; 2024; 18():133-159. PubMed ID: 38283137 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease. Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289 [TBL] [Abstract][Full Text] [Related]
10. Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer's disease: Design, synthesis and biological evaluation. He Q; Liu J; Lan JS; Ding J; Sun Y; Fang Y; Jiang N; Yang Z; Sun L; Jin Y; Xie SS Bioorg Chem; 2018 Dec; 81():512-528. PubMed ID: 30245233 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease. Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883 [TBL] [Abstract][Full Text] [Related]
12. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties. Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535 [TBL] [Abstract][Full Text] [Related]
13. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation. Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents. Ye C; Xu R; Cao Z; Song Q; Yu G; Shi Y; Liu Z; Liu X; Deng Y Bioorg Chem; 2021 Jun; 111():104895. PubMed ID: 33887586 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease. Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132 [TBL] [Abstract][Full Text] [Related]
16. Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapy. Youdim MBH J Neural Transm (Vienna); 2022 Jun; 129(5-6):715-721. PubMed ID: 35190910 [TBL] [Abstract][Full Text] [Related]
17. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties. Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease. Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741 [TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Investigations of Chromone Derivatives as Potential Multitarget-Directed Ligands: Cognitive Amelioration Utilizing a Scopolamine-Induced Zebrafish Model. Kumar N; Jangid K; Kumar V; Yadav RP; Mishra J; Upadhayay S; Kumar V; Devi B; Kumar V; Dwivedi AR; Kumar P; Baranwal S; Bhatti JS; Kumar V ACS Chem Neurosci; 2024 Jul; 15(14):2565-2585. PubMed ID: 38795037 [TBL] [Abstract][Full Text] [Related]
20. Attenuating Aβ1-42-induced toxicity by a novel acetylcholinesterase inhibitor. Mishra N; Sasmal D; Singh KK Neuroscience; 2013 Oct; 250():309-19. PubMed ID: 23872389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]